Related Experiment Video
Updated: Aug 12, 2026
08:31
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
Highlights from the 17th Japan Bioanalysis Forum Symposium
Katsutomo Hata1, Naohito Yamada2, Hiroyuki Shimizu3
1Shionogi & Co., Ltd., Toyonaka, Japan.
Bioanalysis
|August 11, 2026
Summary
The 17th Japan Bioanalysis Forum Symposium highlighted advancements in bioanalysis for drug development. Key topics included regulatory compliance, new therapeutic modalities, and emerging technologies like AI, emphasizing the crucial role of bioanalytical experts.
Area of Science:
- Bioanalytical Science
- Drug Development
- Regulatory Science
Background:
- The 17th Japan Bioanalysis Forum Symposium convened in March 2026.
- The event focused on the future of bioanalytical expertise in drug development.
Purpose of the Study:
- To provide a comprehensive forum for discussing scientific, technological, and regulatory advancements in bioanalysis.
- To foster dialogue on challenges and future directions in the field.
Main Methods:
- The symposium featured 12 sessions with 35 oral presentations and 2 panel discussions.
- Included 38 general poster presentations and 12 discussion group poster sessions.
- Addressed topics such as ICH M10, data integrity, oligonucleotide and gene/cell therapy bioanalysis, antibody-drug conjugates, immunogenicity, biomarker analysis, LC-MS/MS, and ligand-binding assays.
Main Results:
- Active discussions occurred on emerging trends like artificial intelligence and automation in bioanalytical workflows.
- Newly introduced sessions for junior bioanalysts and Casual Follow-Up Sessions promoted open dialogue and engagement.
- Poster sessions and company exhibits facilitated significant scientific exchange.
Conclusions:
- The symposium successfully underscored current challenges and future directions in bioanalysis.
- Reinforced the indispensable role of bioanalytical experts in advancing drug development and regulatory science.
More Related Videos
Related Concept Videos
01:22Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug absorption...
01:13Bioavailability: Overview
Bioavailability refers to the proportion of an unaltered drug that, after administration, enters the systemic circulation and can be distributed to the desired action site. Factors such as gastrointestinal (GI) absorption and liver biotransformation influence the bioavailability of a drug when it is administered orally. When a drug is administered intravenously, it enters the systemic circulation directly; by definition, its bioavailability is assumed to be 100%. The bioavailability of an...
01:17Bioavailability: Overview
Bioavailability refers to the proportion of an administered drug that reaches the systemic circulation in its active, unaltered form. It is a crucial pharmacokinetic parameter that determines the effectiveness of a drug in achieving its intended therapeutic outcomes. The route of administration significantly influences bioavailability, with intravenous administration achieving 100% bioavailability as the drug directly enters the bloodstream. In contrast, oral administration often results in...
01:28Biopharmaceutics and Pharmacokinetics: Overview
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the appropriate...
01:22Bioavailability: Influencing Factors
Bioavailability refers to the extent and rate at which a drug reaches systemic circulation in its active form. Extent refers to the amount of the drug that makes it into circulation, while rate is the speed at which it enters circulation. It is influenced by several factors critical for optimizing drug formulations, dosing regimens, and therapeutic outcomes.Physicochemical properties of drugs and formulationsThe solubility, stability, and dissolution rate of a drug significantly impact its...
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...